XBIO Xenetic Biosciences Inc
Company Analysis
Latest News
🟢 Xenetic Biosciences rises 5.2% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🟢 Xenetic Biosciences is trading 6.39% up with no clear company-specific catalyst
Xenetic Biosciences is trading at $2.34, up 6.39%, with no clear company-specific catalyst identified for the October 6, 2026 move. - The company’s...
🟢 Xenetic Biosciences is trading 6.61% up in pre-market on October 5, 2026 with no clear catalyst
Xenetic Biosciences is trading at $2.39, up +6.61%, with no clear catalyst identified. - Shares are up from the October 2 close of $2.24. - No October 5...
🔴 Xenetic Biosciences is trading 5.79% down today with biotech-sector weakness as partial context
Xenetic Biosciences is trading 5.79% lower at $2.11, with biotech-sector weakness offering only partial context. - The XBI ETF was down 2.01% pre-market. No...
🔴 Xenetic Biosciences is trading 6.7% down in pre-market as biotech weakness offers partial context
Xenetic Biosciences is trading at $2.09, down 6.68% in pre-market; biotech weakness offers context but does not establish the full cause. - The XBI ETF was...
🔴 Xenetic Biosciences is trading 5.9% down amid possible broad-market pressure
Xenetic Biosciences is trading 5.9% down at $2.25 on September 28, 2026; no company-specific announcement explaining the decline was identified. - The latest...
🔴 Xenetic Biosciences is trading 5.66% down today — no confirmed catalyst identified
Xenetic Biosciences is trading 5.66% lower at $2.33, with no company-specific announcement or confirmed catalyst identified for September 25, 2026. - The stock...
🔴 Xenetic Biosciences is trading 6.48% down in pre-market with no clear catalyst identified
Xenetic Biosciences is trading 6.48% lower at $2.31 in pre-market trading, with no company-specific announcement identified for September 25, 2026. - Recent...
🔴 Xenetic Biosciences is trading 6% down today amid broader risk-off trading
Xenetic Biosciences is trading 5.95% down at $2.37, mainly amid broader risk-off trading, with no clear company-specific announcement identified on September...
🔴 Xenetic Biosciences is trading 7.1% down in pre-market with no clear immediate catalyst
Xenetic Biosciences is trading 7.1% lower at $2.34, with no clear immediate catalyst identified. - No new company-specific announcement was identified for...
🔴 Xenetic Biosciences is trading 5% down today
Xenetic Biosciences is trading 5.06% down now at $2.44, with no new company-specific announcement identified for September 23, 2026. - The latest major...
🔴 Xenetic Biosciences Inc is trading 10.37% down
XBIO is trading at $2.68, down 10.37%.
🔴 Xenetic Biosciences is trading 6% down today amid proposed Santersus acquisition uncertainty
Xenetic Biosciences is trading 6.02% down at $2.81 amid volatility surrounding its proposed all-stock acquisition of Santersus AG. - Santersus holders would...
🔴 Xenetic Biosciences is trading 7.36% down today in pre-market amid proposed Santersus acquisition volatility
Xenetic Biosciences is trading 7.36% down now at $2.77 in pre-market amid volatility around its proposed all-stock acquisition of Santersus AG. - Existing...
🟢 Xenetic Biosciences is trading 6.68% up today amid volatility around proposed Santersus acquisition
Xenetic Biosciences is trading at $2.96, up 6.68%, rebounding after volatility around the proposed Santersus acquisition. - It closed at $2.77 on September 18...
🔴 Xenetic Biosciences is trading 6.1% down in pre-market amid volatility following proposed Santersus acquisition
Xenetic Biosciences is trading $2.60 (-6.14%) amid volatility following the proposed all-stock Santersus acquisition, after closing at $2.77 on September 18. •...
🟢 Xenetic Biosciences is trading 11.4% up today following proposed all-stock Santersus acquisition
Xenetic Biosciences is trading 11.4% up at $2.74 amid continued volatility following its proposed all-stock acquisition of Santersus AG. - Santersus...
🟢 Xenetic Biosciences is trading 6.5% up today following proposed all-stock acquisition
Xenetic Biosciences is trading 6.5% up now at $2.62 amid continued volatility following its proposed all-stock acquisition of Santersus AG. - Santersus...
🔴 Xenetic Biosciences is trading 6.4% down today as Santersus shareholders would own 85%
Xenetic Biosciences is trading 6.4% down now at $2.30 as investors continue repricing the proposed all-stock acquisition of Santersus AG. - Under the...
🔴 Xenetic Biosciences is trading 6.1% down in pre-market over dilution concerns tied to proposed Santersus acquisition
Xenetic Biosciences is trading 6.1% down now at $2.31 as investors continue weighing the proposed all-stock acquisition of Santersus AG. - Santersus...